Systems Pharmacology: Defining the Interactions of Drug Combinations
نویسندگان
چکیده
منابع مشابه
Drug interactions and lethal drug combinations.
Although the development of drugs of greater potency and efficacy confers on the physician increasing power to treat serious diseases, it also increases the number and seriousness of potential adverse effects and drug interactions which can occur. Most hospital patients receive more than one drug at a time, the average number often being greater than five (Smith, Seidl, and Cluff, 1966). The in...
متن کاملA quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions
All pharmaceutical companies are required to assess pharmacokinetic drug-drug interactions (DDIs) of new chemical entities (NCEs) and mathematical prediction helps to select the best NCE candidate with regard to adverse effects resulting from a DDI before any costly clinical studies. Most current models assume that the liver is a homogeneous organ where the majority of the metabolism occurs. Ho...
متن کاملManaging Drug Toxicities & Drug Interactions: Clinical Pharmacology Case-based Discussion
Introduction A drug interaction occurs when one drug alters the pharmacological effect (enhanced or decreased) of another drug. In human medicine there are several resources available to screen for drug interactions, and there are specific guidelines and agencies to report suspected drug interactions to. In veterinary medicine screening, monitoring, and reporting of drug interactions are rarely...
متن کاملSystems pharmacology augments drug safety surveillance
Small molecule drugs are the foundation of modern medical practice, yet their use is limited by the onset of unexpected and severe adverse events (AEs). Regulatory agencies rely on postmarketing surveillance to monitor safety once drugs are approved for clinical use. Despite advances in pharmacovigilance methods that address issues of confounding bias, clinical data of AEs are inherently noisy....
متن کاملSystems Pharmacology in Small Molecular Drug Discovery
Drug discovery is a risky, costly and time-consuming process depending on multidisciplinary methods to create safe and effective medicines. Although considerable progress has been made by high-throughput screening methods in drug design, the cost of developing contemporary approved drugs did not match that in the past decade. The major reason is the late-stage clinical failures in Phases II and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annual Review of Pharmacology and Toxicology
سال: 2019
ISSN: 0362-1642,1545-4304
DOI: 10.1146/annurev-pharmtox-010818-021511